compound of formula I, isolated enantiomer, pharmaceutical composition, method for inhibiting mct4 monocarboxylate transporter activity, method for selectively inhibiting mct4 monocarboxylate transporter activity, method for treating a mct4 monocarboxylate transporter mediated disorder and use of a compound
Disclosed herein are compounds and compositions useful in the treatment of mct4-mediated diseases, such as proliferative and inflammatory diseases, which have the structure of formula i: (i) methods of inhibiting mct4 activity in a human or animal subject are also provided. .são revelados no presente documento os compostos e composições úteis no tratamento de doenças mediadas por mct4, como doenças proliferativas e inflamatórias, que têm a estrutura de fórmula i: (i) métodos de inibição atividade de mct4 em um indivíduo humano ou animal também são fornecidos.
